ABP-PUBLISHING
20.4.2021 11:02:09 CEST | Business Wire | Press release
The annual reports inform that the production and, thus, sales grew significantly whereas the audience preferences veered round into health and relations fields.
Besides, in 2021, the publishing house plans to acquire new genres in non-fiction and cooperate with new promising authors, retailers, and markets.
Although the circumstances made the editorial team work remotely, the number of published audiobooks did not diminish but increased. In particular, 109 books were recorded in 2020. The company published, among others, such bestsellers as Educated by Tara Westover, Flow by Mihaly Csikszentmihalyi, and Talking to Strangers by Malcolm Gladwell (German); Money. Master The Game by Tony Robbins, Bad Blood by John Carreyrou, and Big Magic by Elizabeth Gilbert (French); Atomic Habits by James Clear, Outliers by Malcolm Gladwell, and Becoming Supernatural by Joe Dispenza (Italian).
Additionally, in 2020, the publishing house started acquiring new languages producing books in Swedish, Turkish, Spanish, Norwegian, and Japanese.
The increase in production led to the rise in sales, logically. The sales report for 2020 showed a growth of 60 per cent, comparing to 2019. As mentioned, the listeners downloaded more books about health and relations, which is evidence of a slight change in audience preferences.
Further, in 2020, ABP Publishing worked on its ABP Verlag, ABP Editions, and ABP Editore brands. Every subsidiary got a new logotype and site. Moreover, each of the ABP Publishing books can be associated with the publisher, thanks to the standardised cover design.
Following the listeners' interests, in 2021, ABP Publishing plans to release audiobooks in fields and topics the company did not work with before, for instance, publicism and fiction. As an example, the German division has already published Demi Moore's autobiography while the French department is preparing the timeless classic bestseller Atlas Shrugged by Ayn Rand. Besides, the publisher increases the number of titles in relationship and parenting and popular science genres. It is important that despite the growing number of titles, the company keeps the high quality of audiobooks, practising an attentive approach to the voice-overs cast and music and dramatic audiobooks style.
Nevertheless, in the coming years, most publishers in the digital field will face the expansion of subscription and streaming model of distribution. The listeners appreciated the profit of the unlimited access to audiobooks, whereas the publishing houses are switching to a new reality reluctantly. Anyway, all the publishing companies will have to find a balance between listeners' wishes and desirable income. ABP Publishing believes that the changes will be advantageous for all the market participants and cause the better quality of published audiobooks in competitive terms.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210420005017/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NetApp Completes Acquisition of PEAK:AIO to Accelerate Zettabyte-scale AI Deployments2.11.2026 14:00:00 CET | Press release
Acquisition strengthens NetApp Novus, high-performance storage, with differentiated metadata technology and a parallel file architecture purpose-built for AI NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced that it completed the acquisition of PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. With this acquisition, NetApp can leverage metadata services and parallel namespace innovations to power the fastest storage on the planet, NetApp Novus, to support zettabyte-scale file systems for the most demanding workloads of AI clouds and GPU-as-a-service providers. For the best AI infrastructure economics, organizations need to keep GPU resources continuously supplied with data without bottlenecks. The acquisition advances NetApp’s strategy for the next phase of AI infrastructure by bringing PEAK:AIO’s metadata and parallel file system expertise together with NetApp ONTAP, giving customers a path to AI
Bentley Systems Announces Seequent’s Acquisition of Seismic Interpretation Software Company Eliis2.11.2026 14:00:00 CET | Press release
Strengthens Seequent’s subsurface software portfolio, energy and geophysics capabilities, and expands team of specialists Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced that Seequent, The Bentley Subsurface Company, has acquired seismic interpretation software company Eliis. The acquisition will enrich Seequent’s capabilities in geophysics with seismic data interpretation and further advance subsurface understanding to help solve complex global challenges. Eliis’ global team of more than 100 geoscientists, technical specialists, and researchers will join Seequent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261029964674/en/ 3D view from PaleoScan showcasing recent advancements in seismic interpretation workflows that support prospect evaluation and exploration decision-making Founded in 2007 and with headquarters in Montpellier, France, Eliis develops advanced
HistoSonics Receives Regulatory Approval in Singapore, Advancing Expansion Across Asia-Pacific2.11.2026 14:00:00 CET | Press release
HistoSonics today announced that the company has received market authorization from Singapore’s Health Sciences Authority (HSA) for its Edison® Histotripsy System (under the device name HistoSonics Histotripsy System), marking another significant milestone in the company’s continued international expansion and creating new opportunities to advance access to histotripsy throughout the Asia-Pacific region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261102090757/en/ HistoSonics Edison® Histotripsy System The Edison System is a novel, non-invasive, image-guided platform that uses the mechanical properties of focused ultrasound, known as histotripsy, to mechanically destroy and liquefy unwanted tissue and tumors. The technology offers a fundamentally new approach to tissue destruction without the need for invasive procedures, radiation, or thermal energy. The Edison System is currently authorized for the destruction of liver
NIQ Publishes 2026 ESG Progress Report, Highlighting Action Across Climate, People, Communities, and Responsible AI2.11.2026 12:45:00 CET | Press release
Report details NIQ’s continued focus on responsible business, including its first climate risk assessment, expanded employee development and more than 100,000 volunteer hours NIQ (NYSE: NIQ), a leading consumer intelligence company, today released its 2026 Environmental, Social and Governance (ESG) Progress Report, detailing the company’s progress on key ESG priorities throughout 2025. The report covers NIQ’s efforts across environmental responsibility, its people and communities, data integrity, and responsible AI. Key highlights from 2025 include:Strengthened its approach to climate risk and environmental measurement: NIQ conducted its first climate risk assessment aligned with Task Force on Climate-related Financial Disclosures (TCFD) recommendations, tracked Scope 1, 2 and 3 emissions under the GHG Protocol, and externally verified its carbon footprint. Invested in associate development, engagement and well-being: Internal mobility increased to 35%, up from 30%, while performance r
Agenus Announces Nature Medicine Publication of Multicenter UNICORN Phase 2 Trial Demonstrating Deep Responses with Neoadjuvant BOT+BAL in Resectable Colon Cancer2.11.2026 12:42:00 CET | Press release
In pMMR/MSS colon cancer, neoadjuvant BOT+BAL met the trial’s primary endpoint with a 36% major pathologic response rate, including 29% pathologic complete response, within an overall 71% pathologic response rate after one BOT dose and two BAL dosesNo patients treated with BOT+BAL had their cancer return, with median follow-up of 19.2 months in MSS disease and 16.7 months in MSI-H disease; 12-month event-free survival was 100% in both combination cohorts.Independent, multicenter UNICORN findings reinforce the NEST peer-reviewed neoadjuvant evidence supporting Agenus’ planned Phase 3 ROBBIN trial in curative-intent MSS/pMMR colon cancer Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of results from the investigator-sponsored, multicenter Phase 2 UNICORN trial evaluating short-course preoperative, or neoadjuvant, botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, alone or in combination with ba
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
